Washington's decision to join Japan in supporting the battered yen has prompted questions over what motivated the rare ...
CNBC's Kai Nicol-Schwarz discusses how recent AI cyber attacks from models developed by Anthropic and OpenAI have brought ...
AstraZeneca shares dropped as much as 7% after a report that the U.K.'s largest drugmaker was in talks with U.S. peer Bristol Myers Squibb over a megadeal that, if completed, could value the companies ...
U.S. equity futures rose Sunday evening as investors awaited the July jobs report and another busy week of earnings to kick off August trading. Futures tied to the Dow Jones Industrial Average rallied ...
2h
Political voices can't fight against market realities to have a weaker U.S. dollar at the moment: PM
Ten Cap’s Jun Bei Liu says that while a weaker U.S. dollar would support global investor sentiment, potential rate hikes and ...
Louise Loo, Head of Asia Economics at Oxford Economics says Beijing is preparing to deploy a significant arsenal of unspent ...
Feroze Azeez, CEO of Anand Rathi Wealth breaks down the mechanics behind the massive shift in Foreign Institutional Investor ...
Kioxia 's shares are still on a growth trajectory, even after a 40% decline in the past month, thanks to its steady earnings growth, higher demand for its chips amid the AI boom. Shares of the ...
U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.
Kinger Lau of Goldman Sachs said Hong Kong-listed internet platforms are becoming attractive as investors rotate out of ...
Amena Bakr, Head of Middle East and OPEC+ Insights at Kpler says she expects oil prices to continue spiking given the lack of ...
Cyrus Mewawalla, Head of Strategic Intelligence at Globaldata PLC explains that while semiconductor companies may not face an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results